0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Diabetic retinopathy- Epidemiology Forecast to 2028
Published Date: February 2019
|
Report Code: DELV-Epid-418
Home | Market Reports | Health | Health Conditions | Endocrine Conditions
Diabetic retinopathy Epidemiology Forecast to 2028

Diabetic retinopathy- Epidemiology Forecast to 2028

Code: DELV-Epid-418
Report
February 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Diabetic retinopathy - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Diabetic retinopathy epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Diabetic retinopathy Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Diabetic retinopathy in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Diabetic retinopathy outlook. It also includes the explanation of changing trends of epidemiology outlining the Diabetic retinopathy scenario.

Diabetic retinopathy Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Diabetic retinopathy thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Diabetic retinopathy explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Diabetic retinopathy Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Diabetic retinopathy

Key assessments
• Patient Segmentation in Diabetic retinopathy
• Diabetic retinopathy Risk & Burden
• Factors driving growth in a specific Diabetic retinopathy patient population

  1. Report Introduction
    2. Diabetic retinopathy Epidemiology Overview at a Glance
    2.1. Patient Share Distribution of Diabetic retinopathy in 2016
    2.2. Patient Share Distribution of Diabetic retinopathy in 2028
    3. Disease Background and Overview: Diabetic retinopathy
    3.1. Introduction
    3.2. Symptoms
    3.3. Etiology
    3.4. Risk Factors
    3.5. Pathophysiology
    3.6. Diagnosis
    3.7. Treatment
    4. Epidemiology and Patient Population
    4.1. Key Findings
    4.2. Total Prevalent/ Incident Patient Population of Diabetic retinopathy in 7MM
    4.3. Total Prevalent/ Incident Patient Population of Diabetic retinopathy in 7MM – By Countries
    5. Epidemiology of Diabetic retinopathy by Countries
    5.1. United States
    5.1.1. Assumptions and Rationale
    5.1.2. Prevalent/Incident Cases of the Diabetic retinopathy
    5.1.3. Sub-Type Specific cases of the Diabetic retinopathy *
    5.1.4. Sex- Specific Cases of the Diabetic retinopathy*
    5.1.5. Diagnosed Cases of the Diabetic retinopathy
    5.2. EU5
    5.3. Assumptions and Rationale
    5.4. Germany
    5.4.1. Assumptions and Rationale
    5.4.2. Prevalent/Incident Cases of the Diabetic retinopathy
    5.4.3. Sub-Type Specific cases of the Diabetic retinopathy*
    5.4.4. Sex- Specific Cases of the Diabetic retinopathy*
    5.4.5. Diagnosed Cases of the Diabetic retinopathy
    5.5. France
    5.5.1. Assumptions and Rationale
    5.5.2. Prevalent/Incident Cases of the Diabetic retinopathy
    5.5.3. Sub-Type Specific cases of the Diabetic retinopathy*
    5.5.4. Sex- Specific Cases of the Diabetic retinopathy*
    5.5.5. Diagnosed Cases of the Diabetic retinopathy
    5.6. Italy
    5.6.1. Assumptions and Rationale
    5.6.2. Prevalent/Incident Cases of the Diabetic retinopathy
    5.6.3. Sub-Type Specific cases of the Diabetic retinopathy*
    5.6.4. Sex- Specific Cases of the Diabetic retinopathy*
    5.6.5. Diagnosed Cases of the Diabetic retinopathy
    5.7. Spain
    5.7.1. Assumptions and Rationale
    5.7.2. Prevalent/Incident Cases of the Diabetic retinopathy
    5.7.3. Sub-Type Specific cases of the Diabetic retinopathy*
    5.7.4. Sex- Specific Cases of the Diabetic retinopathy*
    5.7.5. Diagnosed Cases of the Diabetic retinopathy
    5.8. United Kingdom
    5.8.1. Assumptions and Rationale
    5.8.2. Prevalent/Incident Cases of the Diabetic retinopathy
    5.8.3. Sub-Type Specific cases of the Diabetic retinopathy*
    5.8.4. Sex- Specific Cases of the Diabetic retinopathy*
    5.8.5. Diagnosed Cases of the Diabetic retinopathy
    5.9. Japan
    5.9.1. Assumptions and Rationale
    5.9.2. Prevalent/Incident Cases of the Diabetic retinopathy
    5.9.3. Sub-Type Specific cases of the Diabetic retinopathy*
    5.9.4. Sex- Specific Cases of the Diabetic retinopathy*
    5.9.5. Diagnosed Cases of the Diabetic retinopathy
    6. Unmet Needs of the Diabetic retinopathy
    7. Appendix
    8. Report Methodology
    8.1. Sources
    9. DelveInsight Capabilities
    10. Disclaimer
    11. About DelveInsight
    *Indication Specific

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Diabetic retinopathy in 7MM
Figure 2: Total Prevalent/Incident Cases of the Diabetic retinopathy in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Diabetic retinopathy in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Diabetic retinopathy in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Diabetic retinopathy in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Diabetic retinopathy in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Diabetic retinopathy in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Diabetic retinopathy in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Diabetic retinopathy in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Diabetic retinopathy in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Diabetic retinopathy in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Diabetic retinopathy in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Diabetic retinopathy in France (2016-2028) *
Figure 14: Diagnosed Cases of the Diabetic retinopathy in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Diabetic retinopathy in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Diabetic retinopathy in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Diabetic retinopathy in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Diabetic retinopathy in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Diabetic retinopathy in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Diabetic retinopathy in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Diabetic retinopathy in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Diabetic retinopathy in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Diabetic retinopathy in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Diabetic retinopathy in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Diabetic retinopathy in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Diabetic retinopathy in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Diabetic retinopathy in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Diabetic retinopathy in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Diabetic retinopathy in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Diabetic retinopathy in Japan (2016-2028)

List of Tables

Table 1: Total Prevalent/Incident Cases of the Diabetic retinopathy in 7MM
Table 2: Total Prevalent/Incident Cases of the Diabetic retinopathy in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Diabetic retinopathy in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Diabetic retinopathy in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Diabetic retinopathy in United States (2016-2028)*
Table 6: Diagnosed Cases of the Diabetic retinopathy in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Diabetic retinopathy in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Diabetic retinopathy in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Diabetic retinopathy in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Diabetic retinopathy in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Diabetic retinopathy in France (2016-2028)
Table 12: Sub-Type Specific cases of the Diabetic retinopathy in France (2016-2028) *
Table 13: Sex- Specific Cases of the Diabetic retinopathy in France (2016-2028) *
Table 14: Diagnosed Cases of the Diabetic retinopathy in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Diabetic retinopathy in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Diabetic retinopathy in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Diabetic retinopathy in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Diabetic retinopathy in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Diabetic retinopathy in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Diabetic retinopathy in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Diabetic retinopathy in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Diabetic retinopathy in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Diabetic retinopathy in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Diabetic retinopathy in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Diabetic retinopathy in UK (2016-2028) *
Table 26: Diagnosed Cases of the Diabetic retinopathy in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Diabetic retinopathy in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Diabetic retinopathy in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Diabetic retinopathy in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Diabetic retinopathy in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

Global Type 1 Diabetes Treatment Market Size Status and Forecast 2021 2027
Global Type-1 Diabetes Treatment Market Size, Status and Forecast 2021-2027

Failure to produce insulin is the cause of this type of diabetes.Market Analysis and Insights Global Type1 Diabetes Treatment MarketThe global Type1 Diabetes Treatment market size is projected to reach US 7034.4 million by 2027 from US 5020 million in 2020 at a CAGR of 4.5 during 20212027.With industrystandard accuracy in analysis and high data integrity the report makes a brilliant attempt to unveil key opportunities available in the global Type1 Diabetes Treatment market to help players in achieving a strong market position.

120 Pages
Type: Report
Code: QYRE-Auto-18I2851
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Self Blood Glucose Monitoring Market Size Status and Forecast 2021 2027
Global Self Blood Glucose Monitoring Market Size, Status and Forecast 2021-2027

Self Blood Glucose Monitoring is an approach whereby people withdiabetesmeasure theirblood sugarglycemia themselves using a glycemic reader.Market Analysis and Insights Global Self Blood Glucose Monitoring MarketThe global Self Blood Glucose Monitoring market size is projected to reach US 18050 million by 2027 from US 11100 million in 2020 at a CAGR of 6.7 during 20212027.With industrystandard accuracy in analysis and high data integrity the report makes a brilliant attempt to unveil key opportunities available in the global Self Blood Glucose Monitoring market to help players in achieving a strong market position.

120 Pages
Type: Report
Code: QYRE-Auto-21E1004
Sat Jul 17 00:00:00 UTC 2021

Add to Cart

Global Pituitary Cancer Market Size Status and Forecast 2021 2027
Global Pituitary Cancer Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-16T5976
Fri Jul 16 00:00:00 UTC 2021

Add to Cart

Global Diabetic Assay Market Size Status and Forecast 2021 2027
Global Diabetic Assay Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-37T1733
Mon Jul 12 00:00:00 UTC 2021

Add to Cart